We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

News   Mar 12, 2018 | Original Story by Tim Stephens for the university of California Santa Cruz.

 
Antigen Study Shows Promise for a Respiratory Syncytial Virus Vaccine

Immune system antibodies can block RSV infection and provide protection from RSV disease. This image shows how a protective human antibody (dark and light grey surface) sticks to a folded part of the RSV G protein antigen (rainbow colored blue-to-red). The new findings provide a foundation for the development of a RSV vaccine. Credit: Rebecca DuBois.

 
 
 

RELATED ARTICLES

Vaccine Can Reduce Likelihood of Severe Pneumonia by Up to 35%

News

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

READ MORE

GlyGen Helps Researchers Answer Glycan-related Questions Using Big Data

News

Of the four building blocks of life – proteins, lipids, nucleic acids and glycans (carbohydrates) – the latter have received the least attention from researchers. This may be about to change as a new project, GlyGen, launches to help researchers answer glycan-related questions using big data.

READ MORE

What Do We Know About the Gut Microbiota in Parkinson’s Disease?

News

According to a new review, current research on the gut microbiome in Parkinson’s disease is promising, but inconsistent and occasionally contradictory.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE